JR
John E Runnells
Director

John E Runnells insider trades: Lifecore Biomedical (LCBM) stock buys and sales

Director, Lifecore Biomedical Last trade Mar 20, 2008 13 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2007
2
Companies
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 20, 2008LCBM↓ Sell$14.3M
Mar 20, 2008LCBM↓ Sell$31K
Apr 4, 2007LCBM↓ Sell10b5-1$112K
Apr 3, 2007LCBM↓ Sell10b5-1$2.3M
Mar 21, 2007LCBM↓ Sell10b5-1$272K
Feb 28, 2007LCBM↓ Sell$690K
Feb 23, 2007LCBM↑ Buy$720K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About John E Runnells's insider trades

John E Runnells is a director at Lifecore Biomedical (LCBM). Since Feb 23, 2007, John has reported 1 open-market purchase worth $720K and 6 sales worth $17.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

3 sales (15% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (5 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LCBM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.